R. Louis (Liège, Belgium), G. Braunstahl (Rotterdam, Netherlands)
Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
L. Ye (shanghai, China), X. Gao (shanghai, China), C. Tu (shanghai, China), C. Du (shanghai, China), W. Gu (shanghai, China), J. Hang (shanghai, China), L. Zhao (shanghai, China), Z. Jie (shanghai, China), H. Li (shanghai, China), Y. Lu (shanghai, China), J. Wang (shanghai, China), X. Jin (shanghai, China), M. Jin (shanghai, China)
|   |
Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland
R. Gawlik (Katowice, Poland), G. Bochenek (Kraków, Poland), D. Brzostek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Brozek (Katowice, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Dobek (Warsaw, Poland), A. Kucharczyk (Warsaw, Poland), M. Kupczyk (Lódz, Poland), I. Kuprys-Lipinska (Lódz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), M. Kowalski (Lódz, Poland)
| |
Should maximal mid-expiratory flow (MMEF) be considered more in COPD?
R. Aktan (Izmir, Turkey), S. Ozalevli (Izmir, Turkey), A. Ozgen Alpaydin (Izmir, Turkey)
| |
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
C. Rhee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea)
| |
Long-Term Remission and Changes in the Severity of Asthma over 30 Years– TRAIL Cohort
O. Tupper (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark)
| |
Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD
J. Gao (Helsinkiolm, Finland), T. Törölä (Helsinkiolm, Finland), C. Li (Stockholm, Sweden), S. Ohlmeier (Oulu, Finland), T. Toljamo (Rovaniemi, Finland), P. Nieminen (Ouluholm, Finland), N. Hattori (Hiroshima, Japan), V. Pulkkinen (Helsinki, Finland), H. Iwamoto (Hiroshima, Japan), W. Mazur (Helsinki, Finland)
| |
Association between lung dysfunction and extra-pulmonary factors in young people
K. Doi (Ube, Japan), T. Hirano (Ube, Japan), K. Murakawa (Ube, Japan), A. Chikumoto (Ube, Japan), Y. Ohteru (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), R. Suetake (Ube, Japan), Y. Murata (Ube, Japan), K. Oishi (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), T. Kakugawa (Ube, Japan), K. Matsunaga (Ube, Japan)
| |
Angiogenic status in patients with chronic obstructive pulmonary disease.
G. Juan Samper (Valencia, Spain), C. Sabater Abad (Valencia, Spain), V. Jaimes Diaz (Valencia, Spain), E. Fernandez Fabrellas (Valencia, Spain), E. Verdejo Mengual (Valencia, Spain), S. Torres (Valencia, Spain), S. Calabuig (Valencia, Spain), I. Martinez (Valencia, Spain)
| |
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
L. Pini (Brescia (BS), Italy), L. Corda (Brescia (BS), Italy), G. Levi (Brescia (BS), Italy), L. Tiberio (Brescia (BS), Italy), C. Rocchetti (Brescia (BS), Italy), M. Arici (Brescia (BS), Italy), J. Giordani (Brescia (BS), Italy), C. Tantucci (Brescia (BS), Italy)
| |
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data
E. Garcia Castillo (Madrid, Spain), T. Alonso Pérez (Madrid, Spain), J. Ancochea Bermúdez (Madrid, Spain), M. Pastor Sanz (Madrid, Spain), J. De Torres (Pamplona, Spain), B. Lamprecht (Linz, Austria), P. Almagro (Terrasa, Spain), P. Martínez Camblor (Hannover, United States of America), M. Miratvilles (Barcelona, Spain), M. Rodríguez Carballeira (terrasa, Spain), I. Alfageme (Sevilla, Spain), A. Ramirez Garcia-Luna, (San Luis de Potosí, Mexico), B. Kaiser (Linz, Austria), C. Casanova (Santa Cruz de Tenerife, Spain), C. Esteban (Vizcaya, Spain), J. Soler Cataluña (Valencia, Spain), B. Celi (Brighton, United States of America), J. Marín (Zaragoza, Spain), P. Sobradillo (Txagorritxu, Spain), P. Lange (Cophenague, Spain), J. Garcia Aymerich, (Barcelona, Spain), J. Anto (Barcelona, Spain), A. Turner (Birmingham, United Kingdom), H. Meilan (Michigan, United States of America), A. Laghammer (Trondheim, Norway), S. Vikjord (Levanger, Norway), A. Stenberg (Baltimore, United States of America), L. Leivseth (Tromso, Norway), A. Johannessen (Haukeland, Norway), O. Toru (Kyoto, Japan), B. Cosío (Palma de Mallorca, Spain), A. Echazarreta (Buenos Aires, Argentina), N. Roche (Paris, France), P. Burgel (Paris, France), D. Sin (Vancouver, Canada), M. Puhan (Zurich, Switzerland), J. López Campos (Sevilla, Spain), A. Navarro (Terrasa, Spain), L. Carrasco (Sevilla, Spain), P. Bakke (Bergen, Norway), J. Soriano (Madrid, Spain)
| |
Hyaluronic acid in COPD exacerbations of different etiology
E. Papakonstantinou (Basel, Switzerland), L. Grize (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Neutrophil-to-lymphocyte ratio and COPD exacerbations in the TIE-study
J. Ellingsen (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Gävle, Sweden), H. Hedenström (Uppsala, Sweden), M. Högman (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Exacerbation burden in mild asthma: Evidence from the NOVELTY study
S. Golam (Cambridge, United Kingdom), M. Sadatsafavi (Vancouver, Canada), M. Alacqua (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), J. Fitzgerald (Vancouver, Canada), T. Harrison (Nottingham, United Kingdom), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Olaguibel (Pamplona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Reddel (Sydney, Australia), C. Janson (Uppsala, Sweden)
| |
Increased plasma fibrinogen could predict frequent exacerbations in asthma
V. Carriero (Orbassano, Italy), F. Bertolini (Orbassano, Italy), A. Sprio (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Iron deficiency and lung function decline in stable COPD – a prospective cohort study
B. Waschki (Hamburg, Germany), T. Zeller (Hamburg, Germany), N. Thomsen (Grosshansdorf, Germany), C. Magnussen (Hamburg, Germany), S. Blankenberg (Hamburg, Germany), K. Rabe (Grosshansdorf, Germany), M. Karakas (Hamburg, Germany), H. Watz (Grosshansdorf, Germany)
| |
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
Y. Jo (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea)
| |
Phenotypic factors as predictors of thrombotic conditionsin patients with chronic obstructive disease
E. Abduganieva (Tashkent, Uzbekistan), L. Irina (Tashkent, Uzbekistan)
| |
Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
A. Corlateanu (Chisinau, Republic of Moldova), E. Scutaru (Chisinau, Republic of Moldova), D. Rusu (Chisinau, Republic of Moldova), O. Corlateanu (Chisinau, Republic of Moldova), S. Covantev (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova)
| |
A novel alert system for impending acute exacerbation of COPD based on cough monitoring.
M. Crooks (Hull, United Kingdom), A. Den Brinker (Eindhoven, Netherlands), R. Van Dinther (Eindhoven, Netherlands), S. Thackray-Nocera (Hull, United Kingdom), C. Wright (Hull, United Kingdom), A. Morice (Hull, United Kingdom)
| |